Mechanisms that protect most high-risk HIV-1 seronegative (HRSN) persons ar
e not well understood. Among hemophiliacs from the Multicenter Hemophilia C
ohort Study who remained HIV-1 seronegative despite a high (94%) risk for a
cquisition of HIV-1 infection, only 7/43 were homozygous for the protective
CCR5 Delta 32 polymorphism. Among the remainder, neither CCR5 density nor
beta -chemokine production, nor in vitro susceptibility to infection with t
he HIV-1 isolate JR-FL could distinguish HRSN hemophiliacs from healthy con
trols. When compared to lymphocytes of healthy controls not at risk for HIV
-1 infection, diminished spontaneous lymphocyte proliferation was seen in l
ymphocytes of HRSN hemophiliacs as well as in lymphocytes of hemophiliacs n
ot at risk for HIV-1 infection. Surprisingly sera/plasmas obtained from hig
hrisk HIV-1 seropositive hemophiliacs prior to seroconversion more often co
ntained alloreactive antibodies than date-matched sera/plasmas obtained fro
m HRSN hemophiliacs. Thus alloreactivity may predispose to acquisition of H
IV-1 infection after parenteral exposure. (C) 2000 Academic Press.